(Q35015106)

5 August 2017

title

Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis (English)

1 reference

5 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Stig P Cramer

4

0 references

Matilda Degn

object named as

Matilda Degn

2

0 references

Finn Sellebjerg

object named as

Finn Sellebjerg

7

0 references

author name string

Signe Modvig

1

1 reference

5 August 2017

Henrik Horwitz

3

1 reference

5 August 2017

Henrik B W Larsson

5

1 reference

5 August 2017

Benedikte Wanscher

6

1 reference

5 August 2017

Jette L Frederiksen

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

8 October 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

8

1 reference

5 August 2017

issue

10

1 reference

5 August 2017

page(s)

e77163

1 reference

Creative Commons Attribution 4.0 International

5 August 2017

copyright license

start time

8 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Intense inflammation and nerve damage in early multiple sclerosis subsides at older age: a reflection by cerebrospinal fluid biomarkers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Will the real multiple sclerosis please stand up?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Inflammatory cortical demyelination in early multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Role of chitin and chitinase/chitinase-like proteins in inflammation, tissue remodeling, and injury.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

In vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Multiple sclerosis cerebrospinal fluid biomarkers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Matrix metalloproteinase-9 and autoimmune diseases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3792899

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

8 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077163

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077163

Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077163

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077163

Acute axonal damage predicts clinical outcome in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077163

CSF abnormalities can be predicted by VEP and MRI pathology in the examination of optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0077163

Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis

21 January 2018

1 reference

12 December 2020

Serum YKL-40 concentrations in patients with early rheumatoid arthritis: relation to joint destruction

1 reference

12 December 2020

Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability

1 reference

12 December 2020

Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system

1 reference

12 December 2020

Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS

1 reference

12 December 2020

Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients

1 reference

12 December 2020

Cerebrospinal fluid measures of disease activity in patients with multiple sclerosis

1 reference

12 December 2020

Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis

1 reference

12 December 2020

Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis

1 reference

12 December 2020

Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis

1 reference

12 December 2020

Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid

1 reference

12 December 2020

Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0077163

Identifiers

DOI

1 reference

5 August 2017

0 references

1 reference

5 August 2017

1 reference